Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;101:e91

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheng, T. O.
Right arrow Articles by Macaya, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheng, T. O.
Right arrow Articles by Macaya, C.
Related Collections
Right arrow Restenosis
Right arrow Valvular heart disease
Right arrow Catheter-based coronary and valvular interventions: other
Right arrow CV surgery: valvular disease

(Circulation. 2000;101:e91.)
© 2000 American Heart Association, Inc.


Circulation Electronic Pages

Long-Term Results of Percutaneous Balloon Mitral Valvuloplasty Using the Inoue Balloon Catheter Technique

Tsung O. Cheng, MD

Professor of Medicine The George Washington University, Washington, DC


*    Introduction
 
To the Editor:

I read with interest the article on long-term follow-up after percutaneous mitral valvuloplasty with the Inoue balloon catheter by Hernandez et al.1 They reported a restenosis rate of 39% at 7 years.

My colleagues from China and I recently reported our experience with the same technique in a follow-up study up to 11 years in the first 202 patients2 among the original 4832 patients treated in China.3 The restenosis rate was 8%, which is very respectable and actually better than that after surgical closed commissurotomy (25% to 28%).2 Why the restenosis rate in the Chinese patients is much lower than that in the Spanish patients is unclear.

Our experience as well as a series of recent reports of excellent long-term results have strengthened the previous conclusion that percutaneous mitral valvuloplasty using the Inoue balloon technique should be the procedure of first choice in most patients with mitral stenosis worldwide.4


*    References
 
1. Hernandez R, Bañuelos C, Alfonso F, Goicolea J, Fernández-Ortiz A, Escaned J, Azcona L, Almeria C, Macaya C. Long-term clinical and echocardiographic follow-up after percutaneous mitral valvuloplasty with the Inoue balloon. Circulation. 1999;99:1580–1586.[Abstract/Free Full Text]

2. Chen C-R, Cheng TO, Chen J-Y, Huang Y-G, Huang T, Zhang B. Long-term results of percutaneous balloon mitral valvuloplasty for mitral stenosis: a follow-up study to 11 years in 202 patients. Cathet Cardiovasc Diagn. 1998;43:132–139.[Medline] [Order article via Infotrieve]

3. Chen C, Cheng TO, for the Multicenter Study Group. Percutaneous balloon mitral valvuloplasty using Inoue technique: a multicenter study of 4832 patients in China. Am Heart J. 1995;129:1197–1204.[Medline] [Order article via Infotrieve]

4. Cheng TO, Holmes DR Jr. Percutaneous balloon mitral valvuloplasty by the Inoue balloon technique: the procedure of choice for treatment of mitral stenosis. Am J Cardiol. 1998;81:624–628.[Medline] [Order article via Infotrieve]

Response

Rosa Hernandez, MD; Camino Bañuelos, MD; Fernando Alfonso, MD; Javier Goicolea, MD; Antonio Fernández-Ortiz; Javier Escaned, MD; Luis Azcona, MD; Carlos Almeria, MD; Carlos Macaya

Hospital Universitario San Carlos, Madrid, Spain


*    Introduction 
 
Dr Cheng remarks on the discrepancy between the restenosis rate reported in our articleR1 (39% at 7 years) and that reported by him and his colleaguesR2 (8%) after percutaneous valvuloplasty with the Inoue balloon. They speculate whether or not baseline differences in Spanish and Chinese populations may account for such a striking difference.

We believe that this difference is more apparent that real. Our restenosis rate after a mean follow-up of 39±23 months was 10%, rather similar to that reported by them (8% after 3.7±2.1 years). A different methodology may account for these differences: (1) Our analysis took . . . [Full Text of this Article]